title: Dual inhibition of Jak2 and STAT5 enhances killing of myeloproliferative neoplasia cells.
authors: M
authors: M
authors: Bar-Natan
authors: E A
authors: EA
authors: Nelson
authors: S R
authors: SR
authors: Walker
authors: Y
authors: Y
authors: Kuang
authors: R J
authors: RJ
authors: Distel
authors: D A
authors: DA
authors: Frank
mesh_terms: D018726:Anti-Dyskinesia Agents / Q000494:pharmacology; D017209:Apoptosis; D004357:Drug Synergism; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors*; D009196:Myeloproliferative Disorders / Q000378:metabolism / Q000473:pathology* / Q000517:prevention & control*; D010868:Pimozide / Q000494:pharmacology*; D050799:STAT5 Transcription Factor / Q000037:antagonists & inhibitors*; D014407:Tumor Cells, Cultured
chemical_list: D018726:Anti-Dyskinesia Agents; D004791:Enzyme Inhibitors; D050799:STAT5 Transcription Factor; D010868:Pimozide; C507924:JAK2 protein, human; D053614:Janus Kinase 2